Vikas Lifecare Limited
Vikas Lifecare Limited engages in manufacturing and trading of polymers, chemicals, iron and steel, and plastic products in India and Ghana. The company operates through Real Estate Division; Trading & Manufacturing Division -Agro; Trading & Manufacturing Division -Polymers; and Trading Division -Infrastructure segments. It offers various polymer compounds, including PE compounds, PVC compounds, … Read more
Vikas Lifecare Limited (VIKASLIFE) - Net Assets
Latest net assets as of March 2025: ₹5.33 Billion INR
Based on the latest financial reports, Vikas Lifecare Limited (VIKASLIFE) has net assets worth ₹5.33 Billion INR as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹7.29 Billion) and total liabilities (₹1.96 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹5.33 Billion |
| % of Total Assets | 73.12% |
| Annual Growth Rate | 27.62% |
| 5-Year Change | 699.77% |
| 10-Year Change | 1029.52% |
| Growth Volatility | 61.77 |
Vikas Lifecare Limited - Net Assets Trend (2015–2025)
This chart illustrates how Vikas Lifecare Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Vikas Lifecare Limited (2015–2025)
The table below shows the annual net assets of Vikas Lifecare Limited from 2015 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹5.33 Billion | +11.45% |
| 2024-03-31 | ₹4.78 Billion | +43.41% |
| 2023-03-31 | ₹3.34 Billion | +67.09% |
| 2022-03-31 | ₹2.00 Billion | +199.47% |
| 2021-03-31 | ₹666.70 Million | +24.56% |
| 2020-03-31 | ₹535.23 Million | -40.59% |
| 2019-03-31 | ₹900.97 Million | +66.97% |
| 2018-03-31 | ₹539.59 Million | +1.06% |
| 2017-03-31 | ₹533.92 Million | +13.10% |
| 2016-03-31 | ₹472.06 Million | +1.51% |
| 2015-03-31 | ₹465.02 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Vikas Lifecare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 444.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹82.78 Million | 1.56% |
| Common Stock | ₹1.86 Billion | 34.97% |
| Other Comprehensive Income | ₹56.88 Million | 1.07% |
| Other Components | ₹3.32 Billion | 62.40% |
| Total Equity | ₹5.32 Billion | 100.00% |
Vikas Lifecare Limited Competitors by Market Cap
The table below lists competitors of Vikas Lifecare Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Louisa Professional Coffee Ltd
TWO:2758
|
$23.36 Million |
|
Optivision Technology
TWO:3666
|
$23.39 Million |
|
Cyan AG
XETRA:CYR
|
$23.39 Million |
|
World Known MFG (Cayman) Limited
TW:4581
|
$23.40 Million |
|
Shougang Concord Grand (Group) Limited
F:CGG
|
$23.36 Million |
|
Erdene Resource Development Corporation
PINK:ERDCF
|
$23.36 Million |
|
Biotoxtech Co. Ltd
KQ:086040
|
$23.35 Million |
|
PermRock Royalty Trust
NYSE:PRT
|
$23.34 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Vikas Lifecare Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,766,892,000 to 5,317,628,000, a change of 550,736,000 (11.6%).
- Net loss of 106,140,000 reduced equity.
- New share issuances of 622,354,000 increased equity.
- Other comprehensive income decreased equity by 166,616,001.
- Other factors increased equity by 201,138,001.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹-106.14 Million | -2.0% |
| Share Issuances | ₹622.35 Million | +11.7% |
| Other Comprehensive Income | ₹-166.62 Million | -3.13% |
| Other Changes | ₹201.14 Million | +3.78% |
| Total Change | ₹- | 11.55% |
Book Value vs Market Value Analysis
This analysis compares Vikas Lifecare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.40x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.14x to 0.40x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-03-31 | ₹0.58 | ₹1.25 | x |
| 2016-03-31 | ₹0.59 | ₹1.25 | x |
| 2017-03-31 | ₹0.67 | ₹1.25 | x |
| 2018-03-31 | ₹0.68 | ₹1.25 | x |
| 2019-03-31 | ₹1.13 | ₹1.25 | x |
| 2020-03-31 | ₹0.67 | ₹1.25 | x |
| 2021-03-31 | ₹0.84 | ₹1.25 | x |
| 2022-03-31 | ₹2.13 | ₹1.25 | x |
| 2023-03-31 | ₹2.54 | ₹1.25 | x |
| 2024-03-31 | ₹3.11 | ₹1.25 | x |
| 2025-03-31 | ₹3.12 | ₹1.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Vikas Lifecare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.21%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 1.37x
- Recent ROE (-2.00%) is below the historical average (1.36%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 0.90% | 0.52% | 1.32x | 1.32x | ₹-42.31 Million |
| 2016 | 1.49% | 0.75% | 1.36x | 1.45x | ₹-40.17 Million |
| 2017 | 1.28% | 0.68% | 1.27x | 1.48x | ₹-46.54 Million |
| 2018 | 1.05% | 0.85% | 0.79x | 1.57x | ₹-48.29 Million |
| 2019 | 2.14% | 0.90% | 0.87x | 2.72x | ₹-70.83 Million |
| 2020 | 2.61% | 0.90% | 0.61x | 4.76x | ₹-39.55 Million |
| 2021 | -5.25% | -4.67% | 0.50x | 2.23x | ₹-101.69 Million |
| 2022 | 14.39% | 9.54% | 0.94x | 1.61x | ₹87.59 Million |
| 2023 | -4.62% | -3.21% | 1.05x | 1.37x | ₹-484.27 Million |
| 2024 | 2.94% | 3.15% | 0.80x | 1.16x | ₹-336.40 Million |
| 2025 | -2.00% | -2.21% | 0.66x | 1.37x | ₹-637.90 Million |
Industry Comparison
This section compares Vikas Lifecare Limited's net assets metrics with peer companies in the Farm Products industry.
Industry Context
- Industry: Farm Products
- Average net assets among peers: $2,272,265,959
- Average return on equity (ROE) among peers: 6.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Vikas Lifecare Limited (VIKASLIFE) | ₹5.33 Billion | 0.90% | 0.37x | $23.36 Million |
| Agri-Tech (India) Limited (AGRITECH) | $163.89 Million | -2.24% | 1.10x | $10.64K |
| Apex Frozen Foods Limited (APEX) | $752.63 Million | 25.18% | 1.38x | $35.67 Million |
| Aspinwall and Company Limited (ASPINWALL) | $1.40 Billion | 5.19% | 0.83x | $5.78 Million |
| Dhampur Bio Organics Limited (DBOL) | $10.11 Billion | 4.60% | 1.29x | $24.22 Million |
| Gillanders Arbuthnot & Company Limited (GILLANDERS) | $1.68 Billion | 15.10% | 2.23x | $5.37 Million |
| The Grob Tea Company Limited (GROBTEA) | $381.05 Million | 4.43% | 0.39x | $1.32 Million |
| Harrisons Malayalam Limited (HARRMALAYA) | $3.17 Billion | 1.24% | 0.61x | $13.65 Million |
| Jayshree Tea & Industries Limited (JAYSREETEA) | $4.29 Billion | 4.75% | 1.54x | $11.97 Million |
| Mangalam Global Enterprise Limited (MGEL) | $608.98 Million | 5.15% | 1.12x | $7.28 Million |
| Norben Tea & Exports Limited (NORBTEAEXP) | $153.03 Million | -2.94% | 0.48x | $5.45 Million |